Tony Bowen, who helped delivered a profit jolt in the just-ended fiscal year, says his successor’s biggest challenge will be investing in AI while protecting the bottom line.

For decades cancer drugmakers have taken a more-is-more model when dosing drugs in clinical trials. U.S. regulators want them to reconsider that approach.

Attention to detail at the top and better execution in stores might be all it takes.

French distiller Pernod Ricard said it anticipates a soft first quarter, marked by further reducing inventories in the U.S. and a challenging macroeconomic environment in China.

The dollar fell as traders waited for U.S. data that could influence the market’s interest-rate cut expectations for the Federal Reserve.

The actor plays a comically capricious Zeus in a series that gives Greek mythology a bawdy, modern-day spin.